...
首页> 外文期刊>Journal of pharmaceutical sciences. >Biodegradable Poly (Lactic-co-Glycolic Acid)-Polyethylene Glycol Nanocapsules: An Efficient Carrier for Improved Solubility, Bioavailability, and Anticancer Property of Lutein
【24h】

Biodegradable Poly (Lactic-co-Glycolic Acid)-Polyethylene Glycol Nanocapsules: An Efficient Carrier for Improved Solubility, Bioavailability, and Anticancer Property of Lutein

机译:可生物降解的聚(乳酸-乙醇酸)-聚乙二醇纳米胶囊:一种有效的载体,可提高叶黄素的溶解度,生物利用度和抗癌性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Lutein bioavailability is limited because of its poor aqueous solubility. In this study, lutein-poly (lactic-co-glycolic acid) (PLGA)-polyethylene glycol (PEG) nanocapsules were prepared to improve the solubility, bioavailability, and anticancer property of lutein. The scanning electron microscopy and dynamic light scattering examination revealed that the nanocapsules are smooth and spherical with size ranging from 80 to 500 nm (mean = 200 nm). In vitro lutein release profile from nanocapsules showed controlled sustainable release (66%) up to 72 h. Aqueous solubility of lutein nanocapsules was much higher by 735-fold than the lutein. Fourier transform infrared spectroscopy analyses showed no chemical interaction among PLGA, PEG, and lutein, indicating possible weak intermolecular forces like hydrogen bonds. X-ray diffraction revealed lutein is distributed in a disordered amorphous state in nanocapsules. Postprandial plasma kinetics (area under the curve) of an oral dose of lutein from nanocapsules was higher by 5.4-fold compared with that of micellar lutein (control). The antiproliferative effect of lutein from nanocapsules (IC50 value, 10.9 M) was higher (43.6%) than the lutein (IC50 value, 25 M). Results suggest that PLGA-PEG nanocapsule is an efficient carrier for enhancing hydrophilicity, bioavailability, and anticancer property of lipophilic molecules such as lutein. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2085-2093, 2015
机译:叶黄素的生物利用度有限,因为其水溶性差。在这项研究中,制备了叶黄素-聚(乳酸-乙醇酸共聚物)(PLGA)-聚乙二醇(PEG)纳米胶囊,以提高叶黄素的溶解度,生物利用度和抗癌性。扫描电子显微镜和动态光散射检查表明,纳米胶囊是光滑且球形的,尺寸范围为80至500 nm(平均= 200 nm)。从纳米胶囊的体外叶黄素释放曲线显示长达72小时的受控可持续释放(66%)。叶黄素纳米胶囊的水溶解度比叶黄素高735倍。傅里叶变换红外光谱分析表明PLGA,PEG和叶黄素之间没有化学相互作用,表明可能存在弱的分子间力,例如氢键。 X射线衍射显示叶黄素以无定形无定形态分布在纳米胶囊中。与胶束叶黄素(对照组)相比,口服纳米叶黄素的餐后血浆动力学(曲线下面积)高5.4倍。叶黄素在纳米胶囊中的抗增殖作用(IC50值为10.9 M)高于叶黄素(IC50值为25 M)(43.6%)。结果表明,PLGA-PEG纳米胶囊是一种有效的载体,可增强亲叶性分子(如叶黄素)的亲水性,生物利用度和抗癌性。 (c)2015年,Wiley Periodicals,Inc.和美国药剂师协会J Pharm Sci 104:2085-2093,2015

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号